#USA #New York #Brydon Group #Rare Diseases #MedComms Experts

MedComms Experts Secures Strategic Investment from The Brydon Group

On February 28, 2025, MedComms Experts (MCE), a prominent global provider specializing in medical communications for rare diseases, announced a significant strategic investment from The Brydon Group. This collaboration is expected to enhance MCE's connectivity with its biopharma clientele and healthcare professionals through precise scientific communication and innovative strategies.

The investment from Brydon will play a crucial role in advancing MCE’s service offerings and integrating new technologies that will help maintain the company’s leadership in scientific creativity and effectiveness. This partnership marks a pivotal moment for MCE, promising to fortify its foundational approaches and expand capabilities in addressing complex medical communication needs.

Wesley Portegies, the founder and current CEO of MedComms Experts, will transition to the role of Chief Strategy Officer. In this new capacity, he will focus on business growth, nurturing client relationships, and driving thought leadership initiatives. Succeeding him as CEO will be John Ribble, who previously held a senior leadership role at Red Nucleus, a firm known for its rapid expansion within the pharmaceutical services sector.

In light of this transition, both leaders expressed optimism about the enhancements to come. Portegies remarked, “Our partnership with The Brydon Group is an exciting advancement for MedComms Experts. Their substantial investment enables us to refine our consultative approach and expand our AI-driven content solutions. My new role focuses on strengthening strategic innovation, ensuring that we continue to set the benchmark for effectiveness in Medical Affairs communication.”

Ribble added, “Taking on this role comes with profound responsibility. The legacy Wesley and his team built over the last twelve years to establish MCE as a leader in the field is remarkable. I am thrilled to join the team and look forward to enhancing our clients’ experiences while innovating ways to achieve growth.”

Kyle Herman, Principal at The Brydon Group, voiced his enthusiasm for the partnership, emphasizing the excellent opportunity to expand MCE’s successes and enhance its capacity to serve existing and future clients.

The transaction has been facilitated with the legal assistance of Goodwin Procter, while Mowery Schoenfeld served as the accounting adviser to The Brydon Group, reinforcing the infrastructure needed to support this strategic collaboration.

About MedComms Experts

MedComms Experts stands as a leading medical communications agency, concentrating on rare diseases. The firm is committed to scientific accuracy and strategic innovation, partnering with biopharmaceutical companies to translate complex science into clear medical messaging. With operational bases in New York and Zurich, MCE empowers Medical Affairs teams by equipping them with the necessary tools for effective engagement with healthcare professionals.

About The Brydon Group

The Brydon Group is an investment firm focused on steady capital growth. By collaborating with seasoned mid-career executives, the firm aims to acquire and operate leading enterprises in healthcare, software, and business services across both governmental and commercial sectors. Their commitment to fostering dynamic growth aligns seamlessly with MCE's objectives for the future.

This partnership not only signifies a new chapter for MedComms Experts but also illustrates an ongoing trend of strategic collaborations aimed at enhancing capabilities in the rare diseases sector, ultimately improving communication strategies and service delivery in the medical communications landscape.